194 related articles for article (PubMed ID: 16825794)
1. The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis.
Binquet C; Quantin C; Le Teuff G; Pagliano JF; Abrahamowicz M; Moreau T
Neuroepidemiology; 2006; 27(1):45-54. PubMed ID: 16825794
[TBL] [Abstract][Full Text] [Related]
2. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
3. Disability and prognosis of relapsing remitting multiple sclerosis, is it different in Iraqi patients?
Hasan ZN
Neurosciences (Riyadh); 2011 Jul; 16(3):233-6. PubMed ID: 21677613
[TBL] [Abstract][Full Text] [Related]
4. Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis.
Young PJ; Lederer C; Eder K; Daumer M; Neiss A; Polman C; Kappos L;
Neurology; 2006 Sep; 67(5):804-8. PubMed ID: 16966541
[TBL] [Abstract][Full Text] [Related]
5. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
6. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of multiple sclerosis in Lebanon.
Yamout B; Itani S; Arabi A; Hamzeh D; Yaghi S
Int J Neurosci; 2010 Mar; 120(3):206-10. PubMed ID: 20374088
[TBL] [Abstract][Full Text] [Related]
8. Predictors of relapse rate in MS clinical trials.
Held U; Heigenhauser L; Shang C; Kappos L; Polman C;
Neurology; 2005 Dec; 65(11):1769-73. PubMed ID: 16344520
[TBL] [Abstract][Full Text] [Related]
9. A composite score to predict short-term disease activity in patients with relapsing-remitting MS.
Sormani MP; Rovaris M; Comi G; Filippi M
Neurology; 2007 Sep; 69(12):1230-5. PubMed ID: 17875911
[TBL] [Abstract][Full Text] [Related]
10. Early relapses, onset of progression, and late outcome in multiple sclerosis.
Scalfari A; Neuhaus A; Daumer M; Deluca GC; Muraro PA; Ebers GC
JAMA Neurol; 2013 Feb; 70(2):214-22. PubMed ID: 23407713
[TBL] [Abstract][Full Text] [Related]
11. Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.
Debouverie M; Laforest L; Van Ganse E; Guillemin F;
Mult Scler; 2009 Feb; 15(2):251-7. PubMed ID: 19181774
[TBL] [Abstract][Full Text] [Related]
12. What is the risk of permanent disability from a multiple sclerosis relapse?
Bejaoui K; Rolak LA
Neurology; 2010 Mar; 74(11):900-2. PubMed ID: 20231665
[TBL] [Abstract][Full Text] [Related]
13. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
D'hooghe MB; Haentjens P; Nagels G; Garmyn M; De Keyser J
Mult Scler; 2012 Apr; 18(4):451-9. PubMed ID: 21952096
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.
Vercellino M; Romagnolo A; Mattioda A; Masera S; Piacentino C; Merola A; Chiò A; Mutani R; Cavalla P
Acta Neurol Scand; 2009 Feb; 119(2):126-30. PubMed ID: 18684216
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.
Leone MA; Bonissoni S; Collimedaglia L; Tesser F; Calzoni S; Stecco A; Naldi P; Monaco F
Mult Scler; 2008 May; 14(4):485-93. PubMed ID: 18208889
[TBL] [Abstract][Full Text] [Related]
16. Predicting beta-interferon failure in relapsing-remitting multiple sclerosis.
O'Rourke K; Walsh C; Antonelli G; Hutchinson M
Mult Scler; 2007 Apr; 13(3):336-42. PubMed ID: 17439902
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for early severity in a childhood multiple sclerosis cohort.
Mikaeloff Y; Caridade G; Assi S; Suissa S; Tardieu M
Pediatrics; 2006 Sep; 118(3):1133-9. PubMed ID: 16951008
[TBL] [Abstract][Full Text] [Related]
18. Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing-remitting multiple sclerosis.
Le Teuff G; Abrahamowicz M; Wynant W; Binquet C; Moreau T; Quantin C
J Clin Epidemiol; 2015 Mar; 68(3):307-16. PubMed ID: 25541382
[TBL] [Abstract][Full Text] [Related]
19. Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.
Langer-Gould A; Popat RA; Huang SM; Cobb K; Fontoura P; Gould MK; Nelson LM
Arch Neurol; 2006 Dec; 63(12):1686-91. PubMed ID: 17172607
[TBL] [Abstract][Full Text] [Related]
20. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
